Ryan Phillips
Associate Director, Strategic Sourcing and Head of Supply Chain Precision Biosciences
Supply chain operations leader in the cell and gene therapy space, experienced across in vivo and ex vivo therapeutic modalities – allogeneic CAR T, viral vector (AAV, LVV), mRNA-LNP, and cell-based vaccines. Able to negotiate and manage contract partnerships for outsourced GMP manufacturing (CMO/CDMOs), clinical research (CROs), cold chain logistics (3PL), and critical raw materials.
Demonstrated experience establishing supply chain foundations (Plan, Source, Make, Deliver) to initiate a global Phase 1 trial of a first-in-human gene editing therapy, including strategy development for secondary packaging, global distribution, and navigating region-specific regulatory requirements.
Early-career experience in big pharma supporting startup of a greenfield vaccine manufacturing site co-sponsored by US Department of Health and Human Services (HHS). Contributed to seasonal influenza production planning, QC throughput improvements, flu-pandemic preparedness, and FDA Pre-Approval Inspection (PAI), culminating in the commercial launch of Flucelvax®, the world’s first cell-based flu vaccine. Capped with an international assignment focused on global ERP implementation.
Seminars
- Moving beyond single-CDMO reliance by building flexible partnership models, including balancing primary and backup manufacturers without overextending budget or timelines. Driving early alignment with CDMOs on process characterization, PPQ strategy, batch sizing, and scale-up assumptions to minimize revalidation risk and accelerate pivotal readiness
- Strengthening supply chain resilience, including strategies for critical raw materials such as lipids and key components
- Establishing effective governance models to enable faster decision-making and seamless execution across partners
